Medium-sized pharmaceuticals companies fight against decreasing margins, the boom of generic medicines and the ubiquitous need to economize. In order to compete in the through the medicines law highly regulated market, the pharma companies must achieve the cost leadership.

This becomes ever more important due to the fact that the Ministries of Health and health insurance companies follow the interest of cost constraints and hence, give preference to lower-priced products. In order to meet those requirements on the market, ambitioned entrepreneurs develop and implement innovative market strategies, strive for continuous globalization, rely on an effective management of commercial excellence and continuously adapt and optimize logistic chains and manufacturing sites in the meaning of an effective supply chain management.

Our objective is to cooperatively develop efficient and reliable business models with our clients in the best regulated market environment in Europe.